Fusion Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.417; its P/E ratio is -15.16; Fusion Pharmaceuticals is scheduled to report earnings on August 6, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23
Income Statement	-
Total Revenue	-	-	$ 2.01M	$ 34.00K	$ 28.00K
Gross Profit	-	-	$ 2.01M	$ 34.00K	$ 28.00K
EBIT	$ -32.05M	$ -25.55M	$ -16.18M	$ -24.14M	$ -23.08M
EBITDA	$ -32.91M	$ -22.21M	$ -16.19M	$ -25.29M	$ -23.91M
Net Income Common Stockholders	$ -33.67M	$ -28.18M	$ -17.25M	$ -25.18M	$ -24.29M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 210.53M	$ 233.61M	$ 191.35M	$ 198.10M	$ 209.84M
Total Assets	$ 323.81M	$ 285.84M	$ 253.38M	$ 268.29M	$ 266.55M
Total Debt	$ 64.55M	$ 50.56M	$ 52.63M	$ 50.62M	$ 50.06M
Net Debt	$ -145.98M	$ -183.05M	$ -138.72M	$ -147.47M	$ -159.78M
Total Liabilities	$ 81.98M	$ 63.36M	$ 64.91M	$ 65.33M	$ 65.72M
Stockholders Equity	$ 241.83M	$ 222.48M	$ 188.47M	$ 202.96M	$ 200.83M
Cash Flow	-
Free Cash Flow	$ -28.64M	$ -19.43M	$ -19.31M	$ -20.29M	$ -26.66M
Operating Cash Flow	$ -27.31M	$ -17.94M	$ -18.84M	$ -19.58M	$ -25.43M
Investing Cash Flow	$ -70.37M	$ -5.24M	$ 13.33M	$ -26.32M	$ -24.53M
Financing Cash Flow	$ 64.01M	$ 57.85M	$ 328.00K	$ 24.31M	$ 59.52M

Currency in USD

Fusion Pharmaceuticals Earnings and Revenue History

Income Statement >

Fusion Pharmaceuticals Debt to Assets

Balance Sheet >

Fusion Pharmaceuticals Cash Flow

Cash Flow >

Fusion Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing